down arrow

Alembic Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE901L01018
  • NSEID: APLLTD
  • BSEID: 533573
INR
840.00
1.5 (0.18%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 87.77 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Rs cr
Consolidate Quarterly Results
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Net Sales
1,692.74
1,647.98
1,561.73
1,516.98
1,630.57
1,594.93
1,486.15
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,692.74
1,647.98
1,561.73
1,516.98
1,630.57
1,594.93
1,486.15
Raw Material Cost
446.91
393.14
405.93
337.38
317.58
413.87
334.19
Purchase of Finished goods
120.18
102.64
95.50
110.54
165.45
88.68
90.24
(Increase) / Decrease In Stocks
-127.55
-66.66
-107.34
-68.55
-22.27
-41.12
-10.91
Employee Cost
397.52
391.47
379.77
401.85
349.28
346.99
348.17
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
595.46
588.12
551.04
475.70
554.16
578.26
525.77
Total Expenditure (Excl Depreciation)
1,432.52
1,408.71
1,324.90
1,256.92
1,364.20
1,386.68
1,287.46
Operating Profit (PBDIT) excl Other Income
260.22
239.27
236.83
260.06
266.37
208.25
198.69
Other Income
9.50
16.74
2.10
3.60
2.89
10.15
11.67
Operating Profit (PBDIT)
269.72
256.01
238.93
263.66
269.26
218.40
210.36
Interest
22.26
18.81
13.18
10.94
15.17
15.69
14.39
Exceptional Items
0.00
12.87
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
247.46
250.07
225.75
252.72
254.09
202.71
195.97
Depreciation
70.04
70.51
69.04
69.48
69.45
67.56
66.18
Profit Before Tax
177.78
180.42
157.03
182.85
184.59
134.64
129.76
Tax
40.08
27.28
22.49
4.64
4.14
-1.92
9.16
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
137.34
152.28
134.22
178.60
180.50
137.07
120.63
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
137.34
152.28
134.22
178.60
180.50
137.07
120.63
Share in Profit of Associates
0.36
0.86
0.32
-0.39
-0.05
-0.51
-0.03
Minority Interest
-0.72
-0.27
-0.17
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
138.42
153.41
134.71
178.21
180.45
136.56
120.60
Equity Capital
39.31
39.31
39.31
39.31
39.31
39.31
39.31
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
7.04
7.81
6.85
9.07
9.18
6.95
6.14
Diluted Earnings per share
7.01
7.79
6.84
8.48
9.23
6.95
6.14
Operating Profit Margin (Excl OI)
15.37%
14.52%
15.16%
17.14%
16.34%
13.06%
13.37%
Gross Profit Margin
14.62%
15.17%
14.46%
16.66%
15.58%
12.71%
13.19%
PAT Margin
8.13%
9.29%
8.61%
11.75%
11.07%
8.56%
8.11%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2024 is 3.81% vs 8.05% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2024 is -23.29% vs 48.01% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2024 is -2.31% vs 7.08% in Dec 2023

stock-summary

Interest

YoY Growth in quarter ended Dec 2024 is 46.74% vs 3.90% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023

Compare Quarterly Results Of Alembic Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,692.74
3,230.00
-1,537.26
-47.59%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,692.74
3,230.00
-1,537.26
-47.59%
Raw Material Cost
446.91
536.11
-89.20
-16.64%
Purchase of Finished goods
120.18
387.30
-267.12
-68.97%
(Increase) / Decrease In Stocks
-127.55
11.81
-139.36
-1,180.02%
Employee Cost
397.52
709.71
-312.19
-43.99%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
595.46
755.27
-159.81
-21.16%
Total Expenditure (Excl Depreciation)
1,432.52
2,400.20
-967.68
-40.32%
Operating Profit (PBDIT) excl Other Income
260.22
829.80
-569.58
-68.64%
Other Income
9.50
77.32
-67.82
-87.71%
Operating Profit (PBDIT)
269.72
907.12
-637.40
-70.27%
Interest
22.26
220.93
-198.67
-89.92%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
247.46
686.19
-438.73
-63.94%
Depreciation
70.04
192.30
-122.26
-63.58%
Profit Before Tax
177.78
497.33
-319.55
-64.25%
Tax
40.08
112.81
-72.73
-64.47%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
137.34
381.08
-243.74
-63.96%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
137.34
381.08
-243.74
-63.96%
Share in Profit of Associates
0.36
3.44
-3.08
-89.53%
Minority Interest
-0.72
4.29
-5.01
-116.78%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
138.42
380.23
-241.81
-63.60%
Equity Capital
39.31
40.06
-0.75
-1.87%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
7.04
9.49
-2.45
-25.82%
Diluted Earnings per share
7.01
9.44
-2.43
-25.74%
Operating Profit Margin (Excl OI)
15.37%
25.69%
0.00
-10.32%
Gross Profit Margin
14.62%
21.24%
0.00
-6.62%
PAT Margin
8.13%
11.90%
0.00
-3.77%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,692.74 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 2.72% vs 5.52% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 3.81% vs 8.05% in Dec 2023

Quarterly - Consolidate Net Profit
Consolidate Net Profit 138.42 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -9.77% vs 13.88% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -23.29% vs 48.01% in Dec 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 260.22 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 8.76% vs 1.03% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -2.31% vs 7.08% in Dec 2023

Quarterly - Interest
Interest 22.26 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 18.34% vs 42.72% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 46.74% vs 3.90% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.37%
in Dec 2024

Figures in Rs %
stock-summary

QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023